Cargando…
Factors affecting the value of diffusion-weighted imaging for identifying breast cancer patients with pathological complete response on neoadjuvant systemic therapy: a systematic review
This review aims to identify factors causing heterogeneity in breast DWI–MRI and their impact on its value for identifying breast cancer patients with pathological complete response (pCR) on neoadjuvant systemic therapy (NST). A search was performed on PubMed until April 2020 for studies analyzing D...
Autores principales: | van der Hoogt, Kay J. J., Schipper, Robert J., Winter-Warnars, Gonneke A., ter Beek, Leon C., Loo, Claudette E., Mann, Ritse M., Beets-Tan, Regina G. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684570/ https://www.ncbi.nlm.nih.gov/pubmed/34921645 http://dx.doi.org/10.1186/s13244-021-01123-1 |
Ejemplares similares
-
Prognostic value of breast MRI characteristics before and during neoadjuvant endocrine therapy in patients with ER+/HER2- breast cancer
por: Ragusi, Max AA, et al.
Publicado: (2021) -
Local staging of ipsilateral breast tumor recurrence: mammography, ultrasound, or MRI?
por: Walstra, Coco J. E. F., et al.
Publicado: (2020) -
Towards the use of diffuse reflectance spectroscopy for real-time in vivo detection of breast cancer during surgery
por: de Boer, Lisanne L., et al.
Publicado: (2018) -
Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study
por: van Loevezijn, Ariane A., et al.
Publicado: (2020) -
Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy
por: Li, Wen, et al.
Publicado: (2022)